Enread
GenAI Research Platform for Life Sciences Leaders
Company Overview
Snapshot
Founded in March 2023 by Yagel Matuky and Tom Guterman, Enread operated with 1–10 employees. The company secured one funding round from one investor. In March 2025, Enread ceased to operate.
Business overview
Enread specialized in developing a generative AI platform designed to enhance productivity for professionals within the life sciences sector. The platform aimed to streamline research processes by automating tasks such as summarizing scientific literature into visual formats, creating interactive comparison tables, extracting experimental protocols, and generating presentations. By integrating with existing software systems, Enread enabled organizations to accelerate workflows and support data-driven decision-making, operating within the Business Software sector, with a focus on IT, R&D & Data Solutions, and Project Management & Collaboration, leveraging Artificial Intelligence and Generative AI technologies for the Healthcare & Life Sciences market.
Log in to access full profile ›Company Intelligence Q&A
- What was Enread's operational status as of March 2025?
- In March 2025, Enread ceased to operate.
- Who founded Enread and when was the company established?
- Enread was founded in March 2023 by Yagel Matuky and Tom Guterman.
- What was the primary technology focus of Enread's platform?
- Enread's platform focused on generative AI to enhance productivity for professionals in the life sciences sector.
- Which sector did Enread primarily operate in?
- Enread's primary sector was Business Software, specifically focusing on IT, R&D & Data Solutions.
- What type of funding did Enread receive in January 2024?
- In January 2024, Enread received a Seed funding round from the Israel Innovation Authority.